Successful treatment of a patient with Li-Fraumeni syndrome and metastatic lung adenocarcinoma harboring synchronous EGFR L858R and ERBB2 extracellular domain S310F mutations with the pan-HER inhibitor afatinib
- Yuxia Jia
- , Siraj M. Ali
- , Shumaila Saad
- , Courtney A. Chan
- , Vincent A. Miller
- , Balazs Halmos
Research output: Contribution to journal › Article › peer-review
14
Link opens in a new tab
Scopus
citations